Miñao, Aivie .

HRN: 05-17-40  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/24/2024
CEFUROXIME 1.5GM (VIAL)
07/24/2024
07/25/2024
IV
1.5gm
Q8 X 2 More Doses
Post OP Prophylaxis
Waiting Final Action 
07/24/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/24/2024
07/25/2024
IV
500mg
Q8 X 3 Doses
Post OP Prophylaxis
Waiting Final Action 
07/25/2024
CEFUROXIME 500MG (TAB)
07/25/2024
07/31/2024
PO
500 Mg
BID
Sp 1 LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: